Evotec SE ADR

Yahoo Finance • last month

Bolivia's Morales barred from running for political office

A constitutional court in Bolivia has barred former President Evo Morales from running again for office, ushering in a new phase in the country's long-running political crisis.... Full story

Yahoo Finance • 4 months ago

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' Wednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago.... Full story

Yahoo Finance • 5 months ago

Super Micro Computer, Airbnb, Rivian and Lyft fall premarket; Shopify rises

Investing.com -- U.S. stock futures rose Wednesday, continuing to rebound after the tech-led rout at the start of the week. Here are some of the biggest premarket U.S. stock movers today Walt Disney (NYSE:DIS) stock fell 0.1% in volatil... Full story

Yahoo Finance • 8 months ago

Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast

Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast European life science company Evotec SE (NASDAQ:EVO) announced a priority reset to optimize its business to meet evolving market demand and focus on profit... Full story

Yahoo Finance • 2 years ago

Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb

KEY SCIENTIFIC ACHIEVEMENTS DRIVE THE EXPANSION OF THE PIPELINE OF MOLECULAR GLUE DEGRADERS PERFORMANCE-BASED AND PROGRAMME-BASED PAYMENTS OF IN TOTAL US$ 75 M TO EVOTEC HAMBURG, GERMANY / ACCESSWIRE / March 16, 2023 / Evotec SE (Frankfur... Full story

Yahoo Finance • 2 years ago

Evotec SE Reports Results for the First Nine Months 2022 and Provides Corporate Update

MULTIPLE NEW AND EXTENDED ALLIANCES IN ALL AREAS PARADIGM SHIFT IN BIOLOGICS STARTING ITS MARKET ENTRY STRATEGY COMMERCIAL LAUNCH OF NEXT-GENERATION MULTI-OMICS DATA ANALYSIS PLATFORM PANHUNTER HAMBURG, GERMANY / ACCESSWIRE / November 9,... Full story

Yahoo Finance • 2 years ago

Evotec SE to Announce Results for the First Nine Months 2022 on 09 November 2022

HAMBURG, GERMANY / ACCESSWIRE / November 3, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for the first nine months 2022 on Wednesday, 09 November 2022. Th... Full story

Yahoo Finance • 2 years ago

Evotec Presents Paradigm Shift in Biologics at Capital Markets Day

TOGETHER FOR MEDICINES THAT MATTER: A PARADIGM SHIFT TO UNLOCK NEW MARKETS AND OPPORTUNITIES FOR GLOBAL ACCESS TO BIOLOGICS BY APPLYING A FULLY INTEGRATED, END-TO-END CONTINUOUS BIOMANUFACTURING PROCESS JUST - EVOTEC BIOLOGICS SELECTED FOR... Full story

Yahoo Finance • 2 years ago

Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership 'Extend' with Leading Italian Academic Institutions

EXTEND AIMS TO DEVELOP DRUG DISCOVERY PARTNERSHIPS WITH LEADING ACADEMIC INSTITUTIONS FROM ITALY TO ACCELERATE THEIR PROMISING THERAPEUTICS FOR COMMERCIALISATION HAMBURG, GERMANY / ACCESSWIRE / October 28, 2022 / Evotec SE (Frankfurt Stoc... Full story

Yahoo Finance • 2 years ago

Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303

- Just – Evotec Biologics will apply its fully integrated technology platform to develop an optimized commercial process for ALPN-303, a Dual BAFF/APRIL Inhibitor for Systemic Lupus Erythematosus and Other Autoimmune and Inflammatory Disea... Full story

Yahoo Finance • 2 years ago

Evotec SE Reports First Half-year 2022 Results on 11 August 2022

HAMBURG, GERMANY / ACCESSWIRE / August 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first half-year 2022 on Thursday, 11 August 2022. The Com... Full story

Yahoo Finance • 2 years ago

Evotec, Boehringer Ingelheim, and bioMérieux Launch Aurobac, a Joint Venture to Fight Antimicrobial Resistance

HAMBURG, GERMANY and FRANCE / ACCESSWIRE / July 6, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO), Boehringer Ingelheim, a leading research-driven biopharmaceutical company, and bioMérieux, a... Full story

Yahoo Finance • 3 years ago

Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures

STRONG FINANCIAL RESULTS: 23% INCREASE IN GROUP REVENUES SIGNIFICANTLY EXCEEDING GUIDANCE DATA-DRIVEN PLATFORMS AND TECHNOLOGIES INCREASE PROBABILITIES OF SUCCESS IN ALL MODALITIES SUBSTANTIALLY STRENGTHENED BALANCE SHEET PROVIDING VERY GO... Full story

Yahoo Finance • 3 years ago

Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb

THE PROGRAMME DESIGNATION IS BASED ON AN ANTISENSE-BASED APPROACH WHICH TRIGGERS A US$ 16 M PAYMENT TO EVOTEC BY BRISTOL MYERS SQUIBB EVOTEC SOURCES LNAPLUS(TM) ANTISENSE TECHNOLOGY THROUGH A STRATEGIC PARTNERSHIP WITH SECARNA PHARMACEUTIC... Full story